Home » Topics » BioWorld Science

BioWorld Science
RSS

Ghost mitochondria drive tumor progression through EIF2AK4/Akt signaling

March 9, 2022

ATH-1020, a novel HGF/MET positive modulator with promising preclinical efficacy

March 9, 2022

BAL-0891 shows potent single agent activity in mouse model of TNBC

March 9, 2022

New lipid nanoparticles allow mRNA delivery to the lung for treating lymphangioleiomyomatosis

March 9, 2022

Zinc oxide nanoparticles target integrin alpha-v beta-3 for breast cancer treatment

March 9, 2022

TNIK Therapeutics presents new prodrugs of TNIK inhibitors

March 9, 2022

P2RX3 antagonists discovered at Tuojie Biotech

March 9, 2022

Nanjing Shunxin Pharmaceutical, Jiangsu Chia Tai Tianqing Pharmaceutical Group patent ADCs

March 9, 2022

New ibuprofen derivatives divulged by Nanjing Heron Pharmaceutical Science and Technology

March 9, 2022

Abbisko Therapeutics identifies new EGFR inhibitors

March 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...